(Q38324216)

2 September 2017

title

Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max (English)

1 reference

2 September 2017

1 reference

Kirch HC

1

1 reference

2 September 2017

Flaswinkel S

2

1 reference

2 September 2017

Rumpf H

3

1 reference

2 September 2017

Brockmann D

4

1 reference

2 September 2017

Esche H

5

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

2 September 2017

1 reference

2 September 2017

volume

18

1 reference

2 September 2017

issue

17

1 reference

2 September 2017

page(s)

2728-2738

1 reference

Reporter genes: application to the study of mammalian gene transcription

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

The mitogenic response to tumor necrosis factor alpha requires c-Jun/AP-1.

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Abnormal structure and expression of p53 gene in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

The Tumor Suppressor p53 Regulates Its Own Transcription

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Definition of a consensus binding site for p53

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases?

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Expression of oncogenes and tumor suppressor genes in human hepatocellular carcinoma and hepatoblastoma cell lines

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Transcription factor AP-1, and the role of Fra-2.

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

CREB-binding protein/p300 are transcriptional coactivators of p65

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Adenovirus E1A negatively and positively modulates transcription of AP-1 dependent genes by dimer-specific regulation of the DNA binding and transactivation activities of Jun.

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

p53; from inductive signal to cellular effect

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Cyclic AMP-Independent ATF Family Members Interact with NF-κB and Function in the Activation of the E-Selectin Promoter in Response to Cytokines

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in int

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Induction of proto-oncogene JUN/AP-1 by serum and TPA.

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Modulation of cell kinetics and cell cycle status by treating CD34 chronic myeloid leukaemia cells with p53 antisense phosphorothioate oligonucleotides.

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53.

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

A novel form of Epstein-Barr virus latency in normal B cells in vivo

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

The mdm-2 gene is induced in response to UV light in a p53-dependent manner

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines.

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Growth regulation of a cellular tumour antigen, p53, in nontransformed cells

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Viruses and apoptosis

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Low p53 protein expression in salivary gland tumours compared with lung carcinomas

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Multifactorial analysis of p53 alteration in human cancer: a review

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function.

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Regulation of apoptosis by viral gene products

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Characterization of the human p53 gene promoter

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

The p53-mdm-2 autoregulatory feedback loop

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

A functional p53-responsive intronic promoter is contained within the humanmdm2gene

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Deletion of the beta-turn/alpha-helix motif at the exon 2/3 boundary of human c-Myc leads to the loss of its immortalizing function

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1202626

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1202626

1 reference

Dimensions Publication ID

2 September 2017

1012514174

0 references

1 reference